<VariationArchive VariationID="1454769" VariationName="NM_001130987.2(DYSF):c.5025_5053dup (p.Thr1685delinsIleCysLeuTrpArgArgThrTer)" VariationType="Duplication" Accession="VCV001454769" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-17" DateCreated="2022-03-28" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1445106" VariationID="1454769">
      <GeneList>
        <Gene Symbol="DYSF" FullName="dysferlin" GeneID="8291" HGNC_ID="HGNC:3097" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="71453561" stop="71686763" display_start="71453561" display_stop="71686763" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="71680752" stop="71913892" display_start="71680752" display_stop="71913892" Strand="+" />
          </Location>
          <OMIM>603009</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001130987.2(DYSF):c.5025_5053dup (p.Thr1685delinsIleCysLeuTrpArgArgThrTer)</Name>
      <CanonicalSPDI>NC_000002.12:71664288:TCTGCCTCTGGAGAAGGACCTAAAGATCA:TCTGCCTCTGGAGAAGGACCTAAAGATCATCTGCCTCTGGAGAAGGACCTAAAGATCA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="71664288" stop="71664289" display_start="71664288" display_stop="71664289" variantLength="29" positionVCF="71664288" referenceAlleleVCF="C" alternateAlleleVCF="CTCTGCCTCTGGAGAAGGACCTAAAGATCA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="71891418" stop="71891419" display_start="71891418" display_stop="71891419" variantLength="29" positionVCF="71891418" referenceAlleleVCF="C" alternateAlleleVCF="CTCTGCCTCTGGAGAAGGACCTAAAGATCA" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.71891419_71891447dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.71891419_71891447dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.71664289_71664317dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.71664289_71664317dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008694.1" sequenceAccession="NG_008694" sequenceVersion="1" change="g.215667_215695dup">
            <Expression>NG_008694.1:g.215667_215695dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130455.2" sequenceAccession="NM_001130455" sequenceVersion="2" change="c.4911_4939dup">
            <Expression>NM_001130455.2:c.4911_4939dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001123927.1" sequenceAccession="NP_001123927" sequenceVersion="1" change="p.Thr1647delinsIleCysLeuTrpArgArgThrTer">
            <Expression>NP_001123927.1:p.Thr1647delinsIleCysLeuTrpArgArgThrTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130976.2" sequenceAccession="NM_001130976" sequenceVersion="2" change="c.4866_4894dup">
            <Expression>NM_001130976.2:c.4866_4894dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124448.1" sequenceAccession="NP_001124448" sequenceVersion="1" change="p.Thr1632delinsIleCysLeuTrpArgArgThrTer">
            <Expression>NP_001124448.1:p.Thr1632delinsIleCysLeuTrpArgArgThrTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130977.2" sequenceAccession="NM_001130977" sequenceVersion="2" change="c.4929_4957dup">
            <Expression>NM_001130977.2:c.4929_4957dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124449.1" sequenceAccession="NP_001124449" sequenceVersion="1" change="p.Thr1653delinsIleCysLeuTrpArgArgThrTer">
            <Expression>NP_001124449.1:p.Thr1653delinsIleCysLeuTrpArgArgThrTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130978.2" sequenceAccession="NM_001130978" sequenceVersion="2" change="c.4971_4999dup">
            <Expression>NM_001130978.2:c.4971_4999dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124450.1" sequenceAccession="NP_001124450" sequenceVersion="1" change="p.Thr1667delinsIleCysLeuTrpArgArgThrTer">
            <Expression>NP_001124450.1:p.Thr1667delinsIleCysLeuTrpArgArgThrTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130979.2" sequenceAccession="NM_001130979" sequenceVersion="2" change="c.5001_5029dup">
            <Expression>NM_001130979.2:c.5001_5029dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124451.1" sequenceAccession="NP_001124451" sequenceVersion="1" change="p.Thr1677delinsIleCysLeuTrpArgArgThrTer">
            <Expression>NP_001124451.1:p.Thr1677delinsIleCysLeuTrpArgArgThrTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130980.2" sequenceAccession="NM_001130980" sequenceVersion="2" change="c.4959_4987dup">
            <Expression>NM_001130980.2:c.4959_4987dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124452.1" sequenceAccession="NP_001124452" sequenceVersion="1" change="p.Thr1663delinsIleCysLeuTrpArgArgThrTer">
            <Expression>NP_001124452.1:p.Thr1663delinsIleCysLeuTrpArgArgThrTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130981.2" sequenceAccession="NM_001130981" sequenceVersion="2" change="c.5022_5050dup">
            <Expression>NM_001130981.2:c.5022_5050dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124453.1" sequenceAccession="NP_001124453" sequenceVersion="1" change="p.Thr1684delinsIleCysLeuTrpArgArgThrTer">
            <Expression>NP_001124453.1:p.Thr1684delinsIleCysLeuTrpArgArgThrTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130982.2" sequenceAccession="NM_001130982" sequenceVersion="2" change="c.5004_5032dup">
            <Expression>NM_001130982.2:c.5004_5032dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124454.1" sequenceAccession="NP_001124454" sequenceVersion="1" change="p.Thr1678delinsIleCysLeuTrpArgArgThrTer">
            <Expression>NP_001124454.1:p.Thr1678delinsIleCysLeuTrpArgArgThrTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130983.2" sequenceAccession="NM_001130983" sequenceVersion="2" change="c.4974_5002dup">
            <Expression>NM_001130983.2:c.4974_5002dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124455.1" sequenceAccession="NP_001124455" sequenceVersion="1" change="p.Thr1668delinsIleCysLeuTrpArgArgThrTer">
            <Expression>NP_001124455.1:p.Thr1668delinsIleCysLeuTrpArgArgThrTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130984.2" sequenceAccession="NM_001130984" sequenceVersion="2" change="c.4932_4960dup">
            <Expression>NM_001130984.2:c.4932_4960dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124456.1" sequenceAccession="NP_001124456" sequenceVersion="1" change="p.Thr1654delinsIleCysLeuTrpArgArgThrTer">
            <Expression>NP_001124456.1:p.Thr1654delinsIleCysLeuTrpArgArgThrTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130985.2" sequenceAccession="NM_001130985" sequenceVersion="2" change="c.4962_4990dup">
            <Expression>NM_001130985.2:c.4962_4990dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124457.1" sequenceAccession="NP_001124457" sequenceVersion="1" change="p.Thr1664delinsIleCysLeuTrpArgArgThrTer">
            <Expression>NP_001124457.1:p.Thr1664delinsIleCysLeuTrpArgArgThrTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130986.2" sequenceAccession="NM_001130986" sequenceVersion="2" change="c.4869_4897dup">
            <Expression>NM_001130986.2:c.4869_4897dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124458.1" sequenceAccession="NP_001124458" sequenceVersion="1" change="p.Thr1633delinsIleCysLeuTrpArgArgThrTer">
            <Expression>NP_001124458.1:p.Thr1633delinsIleCysLeuTrpArgArgThrTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130987.2" sequenceAccession="NM_001130987" sequenceVersion="2" change="c.5025_5053dup" MANESelect="true">
            <Expression>NM_001130987.2:c.5025_5053dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124459.1" sequenceAccession="NP_001124459" sequenceVersion="1" change="p.Thr1685delinsIleCysLeuTrpArgArgThrTer">
            <Expression>NP_001124459.1:p.Thr1685delinsIleCysLeuTrpArgArgThrTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003494.4" sequenceAccession="NM_003494" sequenceVersion="4" change="c.4908_4936dup" MANEPlusClinical="true">
            <Expression>NM_003494.4:c.4908_4936dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003485.1" sequenceAccession="NP_003485" sequenceVersion="1" change="p.Thr1646delinsIleCysLeuTrpArgArgThrTer">
            <Expression>NP_003485.1:p.Thr1646delinsIleCysLeuTrpArgArgThrTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_845" sequenceAccession="LRG_845">
            <Expression>LRG_845:g.215667_215695dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_845t2" sequenceAccession="LRG_845t2">
            <Expression>LRG_845t2:c.5025_5053dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_845p2" sequenceAccession="LRG_845p2" change="p.Thr1685delinsIleCysLeuTrpArgArgThrTer">
            <Expression>LRG_845p2:p.Thr1685delinsIleCysLeuTrpArgArgThrTer</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_845t1" sequenceAccession="LRG_845t1">
            <Expression>LRG_845t1:c.4908_4936dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_845p1" sequenceAccession="LRG_845p1" change="p.Thr1646delinsIleCysLeuTrpArgArgThrTer">
            <Expression>LRG_845p1:p.Thr1646delinsIleCysLeuTrpArgArgThrTer</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2152950672" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001130987.2(DYSF):c.5025_5053dup (p.Thr1685delinsIleCysLeuTrpArgArgThrTer) AND Qualitative or quantitative defects of dysferlin" Accession="RCV001939577" Version="3">
        <ClassifiedConditionList TraitSetID="9586">
          <ClassifiedCondition DB="MedGen" ID="C2931687">Qualitative or quantitative defects of dysferlin</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-02-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001130987.2(DYSF):c.5025_5053dup (p.Thr1685delinsIleCysLeuTrpArgArgThrTer) AND Miyoshi muscular dystrophy 1" Accession="RCV004571722" Version="1">
        <ClassifiedConditionList TraitSetID="1848">
          <ClassifiedCondition DB="MedGen" ID="C4551973">Miyoshi muscular dystrophy 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-01" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-03-28" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17698709</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301480</ID>
          <ID Source="BookShelf">NBK1303</ID>
        </Citation>
        <DescriptionHistory Dated="2024-06-13">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="1848" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2959" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Miyoshi muscular dystrophy 1</ElementValue>
                <XRef ID="MONDO:0024545" DB="MONDO" />
                <XRef ID="C118846" DB="NCI" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MMD1</ElementValue>
                <XRef Type="MIM" ID="254130" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dysferlinopathy includes a spectrum of muscle disease characterized by two major phenotypes: Miyoshi muscular dystrophy (MMD) and limb-girdle muscular dystrophy type 2B (LGMD2B); and two minor phenotypes: asymptomatic hyperCKemia and distal myopathy with anterior tibial onset (DMAT). MMD (median age of onset 19 years) is characterized by muscle weakness and atrophy, most marked in the distal parts of the legs, especially the gastrocnemius and soleus muscles. Over a period of years, the weakness and atrophy spread to the thighs and gluteal muscles. The forearms may become mildly atrophic with decrease in grip strength; the small muscles of the hands are spared. LGMD2B is characterized by early weakness and atrophy of the pelvic and shoulder girdle muscles in adolescence or young adulthood, with slow progression. Other phenotypes in this spectrum are scapuloperoneal syndrome and congenital muscular dystrophy. Asymptomatic hyperCKemia is characterized by marked elevation of serum CK concentration only. DMAT is characterized by early and predominant distal muscle weakness, particularly of the muscles of the anterior compartment of the legs.</Attribute>
                <XRef ID="NBK1303" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Miyoshi Distal Myopathy</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301480</ID>
                <ID Source="BookShelf">NBK1303</ID>
              </Citation>
              <Citation Type="general" Abbrev="AAN, 2017">
                <ID Source="PubMed">25313375</ID>
                <ID Source="pmc">4206155</ID>
              </Citation>
              <XRef ID="45448" DB="Orphanet" />
              <XRef ID="C4551973" DB="MedGen" />
              <XRef ID="MONDO:0024545" DB="MONDO" />
              <XRef Type="MIM" ID="254130" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9586" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9484" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Dysferlinopathy</ElementValue>
                <XRef ID="Dysferlinopathy/2379" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Qualitative or quantitative defects of dysferlin</ElementValue>
                <XRef ID="MONDO:0016145" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Dysferlinopathy includes a spectrum of muscle disease characterized by two major phenotypes: Miyoshi muscular dystrophy (MMD) and limb-girdle muscular dystrophy type 2B (LGMD2B); and two minor phenotypes: asymptomatic hyperCKemia and distal myopathy with anterior tibial onset (DMAT). MMD (median age of onset 19 years) is characterized by muscle weakness and atrophy, most marked in the distal parts of the legs, especially the gastrocnemius and soleus muscles. Over a period of years, the weakness and atrophy spread to the thighs and gluteal muscles. The forearms may become mildly atrophic with decrease in grip strength; the small muscles of the hands are spared. LGMD2B is characterized by early weakness and atrophy of the pelvic and shoulder girdle muscles in adolescence or young adulthood, with slow progression. Other phenotypes in this spectrum are scapuloperoneal syndrome and congenital muscular dystrophy. Asymptomatic hyperCKemia is characterized by marked elevation of serum CK concentration only. DMAT is characterized by early and predominant distal muscle weakness, particularly of the muscles of the anterior compartment of the legs.</Attribute>
                <XRef ID="NBK1303" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2003" />
                <XRef ID="2003" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301480</ID>
                <ID Source="BookShelf">NBK1303</ID>
              </Citation>
              <XRef ID="207073" DB="Orphanet" />
              <XRef ID="C2931687" DB="MedGen" />
              <XRef ID="MONDO:0016145" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4255459" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="13119581|MedGen:C2931687" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002235089" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-02-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17698709</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20301480</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with DYSF-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Thr1646Ilefs*8) in the DYSF gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYSF are known to be pathogenic (PMID: 17698709, 20301480).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DYSF" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.71891418_71891419insTCTGCCTCTGGAGAAGGACCTAAAGATCA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2931687" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9818182" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2024-06-17">
        <ClinVarSubmissionID localKey="NM_003494.4:c.4908_4936dup|OMIM:254130" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005060286" DateUpdated="2024-06-17" DateCreated="2024-06-17" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003494.4:c.4908_4936dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="254130" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9818182" TraitType="Disease" MappingType="XRef" MappingValue="254130" MappingRef="OMIM">
        <MedGen CUI="C4551973" Name="Miyoshi muscular dystrophy 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4255459" TraitType="Disease" MappingType="XRef" MappingValue="C2931687" MappingRef="MedGen">
        <MedGen CUI="C2931687" Name="Qualitative or quantitative defects of dysferlin" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

